The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Anagrelide 0.5 mg Hard Capsules

Athlone Laboratories LtdPA0298/025/001

Main Information

Trade NameAnagrelide 0.5 mg Hard Capsules
Active SubstancesAnagrelide
Dosage FormCapsule, hard
Licence HolderAthlone Laboratories Ltd
Licence NumberPA0298/025/001

Group Information

ATC CodeL01XX Other antineoplastic agents
L01XX35 anagrelide


License statusAuthorised
Licence Issued20/04/2018
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back